Contact Now
Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shaanxi Kaishi Biotechnology Co., Ltd
Product Description
Docetaxel 99% is a high-purity pharmaceutical active pharmaceutical ingredient (API) widely used in oncology drug development and injectable chemotherapy formulations. It belongs to the taxane class of compounds and is a critical intermediate in modern cancer treatment manufacturing pipelines.
As global demand increases for advanced Pharmaceutical Enzymes, Nutritional Ingredients, and high-purity APIs, Docetaxel 99% continues to play a key role in pharmaceutical contract manufacturing and regulated drug production supply chains.
Content Note: Prepared by our technical team based on current scientific literature. Health-related descriptions are intended for research and industrial use only and comply with FDA/EFSA communication guidelines. Last reviewed: June 2026
According to a study in Journal of Clinical Oncology (2004), docetaxel-based chemotherapy regimens demonstrated improved response rates in patients with advanced breast cancer compared with standard treatment protocols.
According to a study in The Lancet Oncology (2008), docetaxel combination therapy showed significant clinical efficacy in non-small cell lung cancer, supporting its role in first-line oncology treatment strategies.
Docetaxel 99% is manufactured under strict GMP-controlled conditions to ensure high purity, stability, and reproducibility for pharmaceutical applications.
| Parameter | Specification |
|---|---|
| Active Ingredient | Docetaxel |
| Purity | ≥ 99% |
| Appearance | White to off-white powder |
| Test Method | HPLC |
| Form | Sterile API powder / injectable intermediate |
| Storage Condition | 2–8°C, protected from light and moisture |
The quality of Docetaxel 99% is strongly influenced by synthesis route, purification technology, and sterile processing systems. Advanced manufacturing ensures compliance with pharmaceutical-grade requirements.
| Process Stage | Impact on Product Quality |
|---|---|
| Semi-synthetic extraction process | Maintains molecular integrity and bioactivity |
| Multi-stage chromatography purification | Reduces impurities and enhances safety profile |
| Sterile freeze-drying process | Improves long-term stability for injectable use |
| Compound | Mechanism | Primary Application |
|---|---|---|
| Docetaxel | Microtubule stabilization | Breast, lung, prostate cancer treatment |
| Paclitaxel | Microtubule inhibition | Broad-spectrum chemotherapy |
| Doxorubicin | DNA intercalation | Solid tumors and hematologic cancers |
Docetaxel 99% is primarily used in pharmaceutical oncology manufacturing and research-based formulation development.
It is also utilized in research contexts involving Plant Extracts , Standardized Extracts, Herbal Extracts , Antioxidants , and Superfood Blends as part of broader nutraceutical and pharmaceutical innovation studies.
We supply Docetaxel 99% under strict pharmaceutical manufacturing standards with global regulatory compliance support.
It is used as an active pharmaceutical ingredient in chemotherapy drug manufacturing for oncology applications.
Yes, it is commonly processed into sterile injectable formulations under GMP conditions.
The standard requirement is ≥99% purity, verified by HPLC testing methods.
It should be stored at 2–8°C in a sealed, light-protected environment.
Yes, OEM and CDMO services are available for global pharmaceutical clients.
Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.